Patent · US Expired

Nucleic acids encoding lymphoid CD30 antigen

US5866372A · kind A · utility

9Cited by
0References
32Claims
0Family size

Inventors

Key dates

Filing dateSep 8, 1994
Grant dateFeb 2, 1999
Priority date
Expiry dateSep 8, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The description relates to the lymphoid surface antigen CD30 (Ki-1) occurring in Hodgkin's disease, the protein sequence and the associated nucleotide sequence therein, manufacture thereof by genetic engineering, methods for diagnosis and investigation of Hodgkin's disease and use of these nucleotide sequences for producing transgenic animals. The invention provides methods not based on monoclonal antibodies for investigation and diagnosis of anaplastic large-cell lymphomas.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.